Retatrutide, developed by Soma Pharmaceuticals , is attracting increasing attention as a novel method for weight management . This dual-action drug combines the activity of a GLP-1 receptor stimulant and a GIP receptor stimulant, intended to effectively promote metabolic improvements but also improve underlying metabolic issues . Initial clinical t